相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Personal neoantigen vaccines induce persistent memory T cell responses and epitope spreading in patients with melanoma
Zhuting Hu et al.
NATURE MEDICINE (2021)
Therapeutic cancer vaccines
Mansi Saxena et al.
NATURE REVIEWS CANCER (2021)
Strong vaccine responses during chemotherapy are associated with prolonged cancer survival
Cornelis J. M. Melief et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Self-Adjuvanting Cancer Vaccines from Conjugation-Ready Lipid A Analogues and Synthetic Long Peptides
Niels R. M. Reintjens et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Peptides conjugated to 2-alkoxy-8-oxo-adenine as potential synthetic vaccines triggering TLR7
Geoffroy P. P. Gential et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2019)
Novel TLR2-binding adjuvant induces enhanced T cell responses and tumor eradication
Gijs G. Zom et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
Ugur Sahin et al.
NATURE (2017)
An immunogenic personal neoantigen vaccine for patients with melanoma
Patrick A. Ott et al.
NATURE (2017)
Vaccination against Oncoproteins of HPV16 for Noninvasive Vulvar/Vaginal Lesions: Lesion Clearance Is Related to the Strength of the T-Cell Response
Mariette I. E. van Poelgeest et al.
CLINICAL CANCER RESEARCH (2016)
Vaccination during myeloid cell depletion by cancer chemotherapy fosters robust T cell responses
Marij J. Welters et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
TLR2 ligand-synthetic long peptide conjugates effectively stimulate tumor-draining lymph node T cells of cervical cancer patients
Gijs G. Zom et al.
ONCOTARGET (2016)
The long-term immune response after HPV16 peptide vaccination in women with low-grade pre-malignant disorders of the uterine cervix: a placebo-controlled phase II study
Peggy J. de Vos van Steenwijk et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2014)
N-Tetradecylcarbamyl Lipopeptides as Novel Agonists for Toll-like Receptor 2
Marian M. J. H. P. Willems et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Efficient Induction of Antitumor Immunity by Synthetic Toll-like Receptor Ligand-Peptide Conjugates
Gijs G. Zom et al.
CANCER IMMUNOLOGY RESEARCH (2014)
HPV16 synthetic long peptide (HPV16-SLP) vaccination therapy of patients with advanced or recurrent HPV16-induced gynecological carcinoma, a phase II trial
Mariette I. E. van Poelgeest et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2013)
An intra-patient placebo-controlled phase I trial to evaluate the safety and tolerability of intradermal IMM-101 in melanoma
J. Stebbing et al.
ANNALS OF ONCOLOGY (2012)
Therapeutic vaccination against human papilloma virus induced malignancies
Sjoerd H. van der Burg et al.
CURRENT OPINION IN IMMUNOLOGY (2011)
Intradermal Vaccinations With RNA Coding for TAA Generate CD8+ and CD4+ Immune Responses and Induce Clinical Benefit in Vaccinated Patients
Susanne M. Rittig et al.
MOLECULAR THERAPY (2011)
An Unexpectedly Large Polyclonal Repertoire of HPV-Specific T Cells Is Poised for Action in Patients with Cervical Cancer
Peggy J. de Vos van Steenwijk et al.
CANCER RESEARCH (2010)
Vaccine provides new hope for patients with deadly brain cancer
[Anonymous]
FUTURE NEUROLOGY (2010)
Success or failure of vaccination for HPV16-positive vulvar lesions correlates with kinetics and phenotype of induced T-cell responses
Marij J. P. Welters et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Immunologic Escape After Prolonged Progression-Free Survival With Epidermal Growth Factor Receptor Variant III Peptide Vaccination in Patients With Newly Diagnosed Glioblastoma
John H. Sampson et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Vaccination against HPV-16 Oncoproteins for Vulvar Intraepithelial Neoplasia.
Gemma G. Kenter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Phase I immunotherapeutic trial with long peptides spanning the E6 and E7 sequences of high-risk human papillomavirus 16 in end-stage cervical cancer patients shows lowtoxicity and robust immunogenicity
Gemma G. Kenter et al.
CLINICAL CANCER RESEARCH (2008)
Skin reactions to human papillomavirus (HPV) 16 specific antigens intradermally injected in healthy subjects and patients with cervical neoplasia
Muriel van den Hende et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Distinct uptake mechanisms but similar intracellular processing of two different Toll-like receptor ligand-peptide conjugates in dendritic cells
Selina Khan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
分享论文
